ConductScience.org, home

Paper4373589

Successful medical adrenalectomy with amino-glutethimide. Role of altered drug metabolism.

Santen RJ and 2 others. JAMA, 1974. Cited by 150 papers, by iCite.

Cite this record

ConductScience Library. Successful medical adrenalectomy with amino-glutethimide. Role of altered drug metabolism. Papers, record 4373589. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4373589

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Successful medical adrenalectomy with amino-glutethimide. Role of altered drug metabolism.
PubMed
Journal
JAMA
PubMed
Year
1974
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
150
iCite
Relative citation ratio, by iCite
5.47
iCite
Revised in PubMed
2018-11-30
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Santen RJR J
2Lipton AA
3Kendall JJ

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenal Cortex HormonesMajor topic
Adrenal GlandsMajor topic
AminoglutethimideMajor topic
Breast NeoplasmsMajor topic
DexamethasoneMajor topic
Adrenalectomy
Adrenocorticotropic Hormone
Adult
Aged
Drug Interactions
Female
Half-Life
Humans
Hydrocortisone
Middle Aged
Neoplasm Metastasis
Secretory Rate

Source PubMed

Download CSV of topics

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 150 citations.

PMIDTitleJournalYearIn PapersSource
23625614Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved.Endocr Relat Cancer2013https://conductscience.org/library/papers/23625614PubMed
16202169The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment.Reprod Biol Endocrinol2005https://conductscience.org/library/papers/16202169PubMed
8595171Therapeutic effects of the aromatase inhibitor fadrozole hydrochloride in advanced breast cancer.Br J Cancer1996https://conductscience.org/library/papers/8595171PubMed
7749129Aromatase inhibitor development for treatment of breast cancer.Breast Cancer Res Treat1995https://conductscience.org/library/papers/7749129PubMed
7619329Antineoplastic agents. Drug interactions of clinical significance.Drug Saf1995https://conductscience.org/library/papers/7619329PubMed
7238450Factors affecting adrenocortical hormone function.Environ Health Perspect1981https://conductscience.org/library/papers/7238450PubMed
6690067Aminoglutethimide and warfarin. A new important drug interaction.Cancer Chemother Pharmacol1984https://conductscience.org/library/papers/6690067PubMed
6293627Suppression of estrogens with aminoglutethimide and hydrocortisone (medical adrenalectomy) as treatment of advanced breast carcinoma: a review.Breast Cancer Res Treat1981https://conductscience.org/library/papers/6293627PubMed
6221746Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer.Br J Cancer1983https://conductscience.org/library/papers/6221746PubMed
4042517Single-dose and steady-state pharmacokinetics of aminoglutethimide.Clin Pharmacokinet1985https://conductscience.org/library/papers/4042517PubMed
3912013Could aminoglutethimide replace adrenalectomy?Breast Cancer Res Treat1985https://conductscience.org/library/papers/3912013PubMed
3779118Aminoglutethimide-induced myelosuppression.Breast Cancer Res Treat1986https://conductscience.org/library/papers/3779118PubMed
3719899The influence of a graded dose schedule of aminoglutethimide on the disposition of the optical enantiomers of warfarin in patients with breast cancer.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3719899PubMed
3436111Alterations in the metabolism of oestrogens during treatment with aminoglutethimide in breast cancer patients. Preliminary findings.Clin Pharmacokinet1987https://conductscience.org/library/papers/3436111PubMed
3358910The effects of aminoglutethimide and hydrocortisone, alone and combined, on androgen levels in post-orchiectomy prostatic cancer patients.Br J Cancer1988https://conductscience.org/library/papers/3358910PubMed
3048976Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer.Drugs1988https://conductscience.org/library/papers/3048976PubMed
2963170On the role of additive hormone monotherapy with tamoxifen, medroxyprogesterone acetate and aminoglutethimide, in advanced breast cancer.Klin Wochenschr1987https://conductscience.org/library/papers/2963170PubMed
2679845Treatment of breast cancer with aromatase inhibitors--current status and future prospects.Br J Cancer1989https://conductscience.org/library/papers/2679845PubMed
1847846Pharmacokinetics and pharmacodynamics of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione in patients with postmenopausal breast cancer.Cancer Chemother Pharmacol1991https://conductscience.org/library/papers/1847846PubMed
1505141Clinical pharmacokinetics of endocrine agents used in advanced breast cancer.Clin Pharmacokinet1992https://conductscience.org/library/papers/1505141PubMed

See all 23 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4373589

GET https://conductscience.org/api/papers/v1/4373589/cited_by?page=2